Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Jenapharm describes scavestrogens, a novel class of nonfeminizing estrogens

July 23, 1998

L-054264, the first small-molecule sst2 receptor agonist reported

July 22, 1998

SomatoKine progresses to phase II for a new disease indication

July 22, 1998

Kos files European marketing application for Niaspan and begins clinical trials with Nicostatin

July 22, 1998

Yoshitomi prepares agents for hyperuricemia and gout

July 21, 1998

Arylureas and arylmethylcarbamoyl derivatives as ACAT inhibitors

July 21, 1998

Increased sexual activity in Muse-treated men does not mean increased risk of CV side effects

July 21, 1998

Generex submits IND for Oralin in Canada

July 21, 1998

Sanwa Kagaku licenses Bayer antidiabetic agent for Japanese development

July 20, 1998

New treatment for male hypogonadism introduced in Germany

July 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...